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Mycoplasma neurolyticum elaborates, in broth cultures, a  soluble  exotoxin which 
causes rolling disease in mice. Some of the properties of the toxin, and the neuropatho- 
logic lesions which it causes, are described  in the preceding paper (1). 
The organisms themselves,  removed from broth cultures and washed by centrif- 
ugation, are known to possess the same kind of neurotoxicity (2, 3). The neurological 
manifestations, incubation period, time of death, and pathologic lesions in the brains 
of mice and rats are indistinguishable  from those caused by the soluble exotoxin. Does 
this mean that the whole, live mycoplasmas contain preformed toxin, which is released 
when they are injected into the animal? Or instead of acting as simple vehicles for the 
toxin, do they synthesize and then release it after being injected? 
The S-6 strain of Mycoplasma gallisepticum, which causes an encephalopathy with 
polyarteritis of the cerebral arteries in turkeys (4, 5) was shown in this laboratory to 
resemble M. neurolyticum with respect to the acute neurotoxieity exhibited by sus- 
pensions of concentrated, washed organisms (5). Within 1 to 2 hr after an intravenous 
injection of a concentrated suspension of M. gallisepticum, turkey poults became atax- 
ie, then paralyzed, and died in a  few hours with generalized  convulsions.  With M. 
gaUisepticum, however, no soluble toxin could be demonstrated in broth cultures, nor 
was toxin present in myeoplasma disrupted by freezing and thawing. Moreover, birds 
were protected against the toxin by pretreatment with tetracydine or gold thiomalate. 
For these reasons it was concluded that this organism does not contain toxin, but pro- 
duces it soon after being injected into the turkey (5). 
It will be shown in  this paper that  a  similar state of affairs exists for M. 
neurolyticum.  Although this organism produces exotoxin when grown in broth 
cultures, concentrated suspensions of the washed mycoplasmas do not contain 
demonstrable toxin,  and mice and  rats  can be protected  against  toxicity by 
tetracycline.  The  capacity  of  resting  mycoplasmas  to  synthesize  exotoxin 
rapidly in vitro will be demonstrated. 
Materials  and Methods 
The A strain of M. neurolytivura  was obtained from Dr. Joseph Tully of the National In- 
stitutes of Health. The organism was grown and maintained in PPLO media as previously 
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described (1), and suspensions of intact mycoplasmas were obtained from 18 to 20 hr broth 
cultures by centrifugation at 12,000 g for 30 min and washed 3 times in Ringer's solution. The 
final pellet was resuspended in a volume of Ringer's representing a  100-fold concentration of 
the original broth culture. In most instances, this suspension contained approximately 1011 
colony-forming units per ml, as determined by titration on PPLO sgar plates. 
RESULTS 
Similarities between Neurotoxic Properties of Whole Mycoplasma and the Exotoxin 
Intravenous  injection  of  suspensions  of  the  washed,  intact  mycoplasmas 
resulted in neurologic manifestations which were indistinguishable from those 
caused by the exotoxin. Depending  upon  the  dosage,  the  incubation period 
TABLE  I 
TiJraJion of Suspcmsion of Wasked, Concentrated Mycoplasma, by Intravenous 
Injection 
Dilution of  Time o| onset of rolling  Time of death  Incidence of 
suspension*  death 
Undiluted 
1--4 
1-8 
1-16 
5,  5,  8,  10,  10 
5,  5,  20,  30,  30 
30,  30,  60,  120,  - 
8,  10,  20,  60,  60 
10,  30,  60,  60,  60 
120,  120, 240, 240, - 
s/s 
s/s 
4/s 
o/s 
* Mycoplasmas in 20-hr broth cultures centrifuged, washed 3  X  in Ringer's solution, and 
suspended to make 100 X  concentration over original culture. Each ml contains 10  n  colony- 
forming units. Dilutions made in Ringer's solution. Each mouse received 0.5 ml. 
ranged from 5 min to 2}6 hr. The mice exhibited the same kind of continual 
rolling movements, and rats became comatose with the same sort of paralysis 
and  clonic convulsive movements  of the  extremities. Death  in both species 
usually occurred within 4  hr.  The occasional animals  which survived for 18 
hours or longer showed similar lesions of spongiform hemispheres. Young mice 
and rats were more susceptible than older animals. 
The toxicity of whole mycoplasmas was  closely related to the number of 
organisms injected. The relation of dosage to the time of onset and death is 
illustrated  in Table I.  High  doses,  i.e.  5  )<  101° mycoplasmas  contained in 
0.5 ml,  caused rolling and death within 20 min or less  after intravenous in- 
jection, while lower doses were associated with incubation periods as long as 
2 hr and death after 4 hr. The same "all-or-none" phenomenon was observed; 
in general, a dose sufficient to cause roiling in 1 animal affected all mice in the 
group similarly, while slightly smaller amounts caused neither roiling nor death 
in any animals. 
Although typical rolling disease was produced with regularity when sufficient 
number of mycoplasmas were injected, the mycoplasmas did not remain viable LEWIS  THOMAS AND  MARK. W.  BITENSKY  1091 
for a long time in animals  which survived the initial effects of the toxin.  Mice 
injected with doses of mycoplasmas just short of lethal had negative cultures 
for M. neurolyticura in homogenates of their brains, hearts, kidneys, livers,  and 
spleens 48 hr after injection. Even when the mycoplasmas were injected intra- 
cerebrally, the brains of animals  surviving for 3 days or longer were sterile 
when cultured for mycoplasma. 
Failure of the organisms  to replicate undoubtedly explains  the absence of 
delayed rolling disease in animals  receiving  less than threshold doses of myco- 
plasmas. 
TABLE II 
Protection by Tetracycline against Neurotoxicity of Suspensions of Mycoplasmas 
Group  Dilution of  Incidence  of Rolling  Incidence  of death 
suspension s  disease 
Tetracycline~ 
Untreated controls 
1-2 
1-4 
1-8 
1-2 
1-4 
1-8 
5/10 
0/10 
0/10 
lO/lO 
ao/xo 
lO/lO 
5/10 
0/10 
0/10 
lO/lO 
lO/IO 
lO/iO 
* Suspension prepared as indicated in Table I. 
Tetracycline administered intraperitoneaUy in dose of 0.5  nag per mouse,  1 hr 
injecting mycoplasma suspensions. 
before 
The thermolability of the toxic property of whole organisms  was the same as 
previously observed with the exotoxin.  Heating for 15 m~n at 45°C eliminated 
toxicity from suspensions  of mycoplasmas, and the organisms  were killed by 
exposure to this temperature. 
Differences between Organisms and Exotoxin 
Tetracycline Protection.--Pretreatment of mice and rats with tetracycline, in 
a dose of 1.5 mg given intraperitoneally 30 rain  before the injection of myco- 
plasmas, protected the animals  against rolling disease and death (Table II). No 
protection was provided by tetracycline against the neurotoxicity of the soluble 
exotoxin,  indicating  that  the  organisms  must  be metabolically active  after 
injection in order to produce neurotoxin. 
Antibody  Protection.--In contrast with the previously reported experiments 
with the exotoxin,  in which solid protection against 5 ~.L.D.'S of toxin was pro- 
vialed by intravenous antibody given just before or within 3 rain after toxin (1), 
antibody had relatively little effect on the neurotoxicity of the whole organisms. 
Table III illustrates a typical experiment. Antibody was partially effective in 1092  STIYDIES O1  ¢ PPLO IN~ECTION. IV 
preventing death at the end point dilution of mycoplasma toxicity, but slightly 
larger amounts of mycoplasma suspension were unaffected. 
Route of Infection.--It  was previously noted that the exotoxin was effective 
only when injected by vein, and failed to cause rolling disease when injected 
intracerebrally or intraperitoneaUy. In contrast,  the  neurotoxicity of suspen- 
sious  of  living  mycoplasmas  was  the  same  or  slightly  greater  when  given 
by the  intraperitoneal  route,  and  substantially greater  when  injected  intra- 
cerebrally (Table IV). It would appear that the organisms are able to elaborate 
TABLE III 
Protection of Mice against Neurotoxicity of Mycoplasraa by Antibody 
Antibody*  Dilution of suspensions  Incidence of death 
Anti-A 
Anti-KSA 
Normal Serum 
1-2 
1--4 
1-8 
1-16 
1-2 
1-4 
1-8 
1-16 
1-2 
1-4 
1-8 
1-16 
6/6 
6/6 
3/6 
0/6 
6/6 
6/6 
6/6 
0/6 
6/6 
6/6 
6/6 
0/6 
* Rabbit antiserum diluted 1 to 2, administered in dose of 0.5 ml 5 min before 
mycoplasma suspension. 
$ As indicated in Table I. 
injection of 
toxin which  is not bound  or inactivated in these sites,  or perhaps are trans- 
ported to other sites. It is difficult to explain the marked increase in toxicity 
of intracerebrally injected mycoplasmas, in view of the ineffectiveness of toxin 
itself by this  route.  It may be that  the  organisms are capable of producing 
toxin which reaches sites within the brain which are not affected by an injection 
of the toxin alone. 
Effect of Freezing and Thawing.--Disruption  of a suspension of whole myco- 
plasmas by 10  cycles of freezing at  --70°C, followed by thawing,  resulted in 
complete loss of neurotoxicity. Such treatment had no effect on the capacity of 
exotoxin to cause rolling disease and death.  As with the above observations, 
this indicates that the mycoplasmas must be alive and intact to be neurotoxic, 
since they do not contain sufficient preformed toxin to account for their toxicity. 
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suspensions of the sedimentable component of normal rat brain to inactivate 
the toxin of M. neurolyticum was described previously, and a similar property 
of water-soluble brain ganglioside was reported (1). These preparations, how- 
ever, had no effect on the toxicity of suspensions of intact mycoplasmas. In- 
cubation of mycoplasma suspensions  at 37°C  with  equal volumes of a  10% 
suspension of the 13,000  g sediment of brain, followed by intraperitoneal in- 
jection  of  the  mixture,  did  not  reduce  the  lethal  titer  of  the  organisms. 
Similarly,  exposure of  washed  mycoplasmas  to  a  ganglioside  solution,  in  a 
concentration of 1 mg per ml, caused no change in toxicity. 
TABLE IV 
Neurotoxicity of Mycoplasmas Injected by Different Routes 
Route of Injection  Dilution of  Incidence of  Incidence of 
suspension  rolling disease  death 
Intravenous (0.4 ml) 
Intraperitoneal (0.4 ml) 
Subcutaneous (0.4 ml) 
Jntracerebral (0.02 ml) 
1-2 
1-4 
1-8 
1-16 
1-2 
1-4 
1-8 
1-16 
1-2 
1-4 
1-8 
1-2 
1-4 
1-8 
1-16 
6/6 
6/6 
6/6 
0/6 
6/6 
6/6 
6/6 
4/6 
0/6 
0/6 
0/6 
6/6 
6/6 
2/6 
0/6 
6/6 
6/6 
6/6 
0/6 
6/6 
6/6 
6/6 
4/6 
0/6 
0/6 
0/6 
6/6 
6/6 
2/6 
0/6 
The  observation  is  interpreted  to  conform with  other  evidence that  the 
organisms do not contain toxin in available form, and produce it only after 
being injected into the animal. 
Production of Toxin by Resting Mycoplasmas in Vitro 
Since the  incubation periods  after injection of the  whole organisms  were 
similar to those seen with the exotoxin, it may be assumed  that  the myco- 
plasmas  are  capable  of synthesizing  and  releasing  exotoxin very soon  after 
being injected. It is difficult to imagine this occurring as a function of multipli- 
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as reported above, the evidence from cultures of the brain and heart indicates 
that M. neurolyticum does not multiply after intravenous injection. 
The capacity of resting, nonreplicating mycoplasmas to synthesize toxin was 
therefore studied. 
Production o/ Toxin  by  "Resting"  Mycoplasmas.--A  concentrated, washed 
suspension of mycoplasmas, containing 1011 organisms per ml, was suspended 
in an equal volume of PPLO broth. One-half of the mixture was held at 0°C for 
30 min, while the remainder was incubated at 37°C for 30 min. Both were then 
chilled and centrifuged in the cold at 13,000 g for 15 min, and the supernatant 
fluid tested for neurotoxicity in mice. Toxin appeared in the broth incubated 
at 37°C in concentrations comparable to 20-hr broth cultures, while no toxin 
was demonstrable in the broth held at 0°C. 
It was thus evident that the mycoplasmas were capable of producing toxin 
within 30 rain or less. 
In order to learn whether all components of the PPLO broth were needed 
for toxin production, a suspension of washed mycoplasmas (5 X  101° organisms 
per ml) in Ringer's solution was placed in a dialysis sac, which was submerged 
in PPLO broth and incubated on a shaker at 37°C. Samples of the suspension 
were removed after various intervals, centrifuged at 13,000 g for  15 min, and 
the supernatant tested in mice. The results are shown in Table V. At 5 min, 
no toxin was demonstrable in the supernate, but beginning at 15 rain and con- 
tinuing for 2 hr substantial quantities of toxin were produced. At 2~/~ hr the 
level of toxin decreased sharply, and at this time the remaining organisms in 
the sac were removed, rewashed 3 times in Ringer's, suspended to volume in 
Ringer's, placed in a new dialysis sac, and submerged in fresh broth. No further 
toxin was produced by these organisms over a subsequent incubation period of 
2 hr. 
The capacity of the organisms to produce toxin in the absence of nutrients 
was next tested. Washed mycoplasmas, 5  X  101° organisms per ml, were sus- 
pended in Ringer's solution containing 0.1 M phosphate buffer at several dif- 
ferent pH levels, ranging from 6.0 to 8.0. No toxin was formed during an hour 
of incubation. However, the addition of glucose yielded toxin within 30 rain. 
The quantity of toxin produced was somewhat less than with mycoplasmas in 
broth, suggesting that nutrients other than glucose are also needed for toxin 
production. The optimal pH was 7.5; the optimal concentration of glucose was 
0.5 mg per ml. No toxin was produced by the same suspensions held at 0°C 
for 1 hr. These observations are summarized in Table V. 
The toxin formed by resting mycoplasmas was  inactivated by trypsin,  as 
was  shown  previously for  the  toxin  contained  in  crude broth  filtrates  (1). 
The effects of several antibiotics on toxin production by resting mycoplasmas 
were examined, with results indicated in Table VL Puromycin, in concentra- 
tions of 5  and  1 /~g per ml,  completely prevented toxin production during  a 
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TABLE V 
Production  of Toxin by Resting Mycoplasmas 
Medium for suspension of mycoplasma 
Ringer's solution, in dialysis sac submerged 
in PPLO broth 
Glucoses phosphate bufferS, pH 7.5 
Glucoses phosphate bufferS,  pH 6.5 
Glucoses phosphate bufferS,  pH 7.0 
GlucoseS phosphate bufferS, pH 8.0 
Phosphate buffer pH 7.5, no glucose 
Time of 
incubation 
5min 
15  " 
30  " 
60  " 
2 hr 
2~ hr 
5 min 
15  " 
30  " 
60  " 
2 hr 
30 min 
30  " 
30  " 
15 min 
30  " 
60  " 
Toxin in supernatant  fluid* 
37oC  ooc 
0  0 
++  0 
++++  0 
++++  0 
++  0 
0  0 
0  0 
++  0 
++++  0 
++  0 
0  0 
++  0 
++  0 
++  0 
0  0 
0  0 
0  0 
* Duplicate tubes incubated for indicated times at 37 ° and 0°C. Four mice tested for each 
sample, by intravenous injection of 0.5 ml and 0.1 ml of the supematant fluid obtained by 
centrifuging each suspension at  13,000 g for 15 mill, after incubation.  Rolling disease and 
death with 0.1 mi indicated by ++++;  with 0.5 ml, but not 0.1 mi, indicated by ++. 
:~ Phosphate buffer, 0.1 M, containing 0.5 mg/ml glucose. 
TABLE VI 
Effect of Antibiotics on Toxin Production  by Resting Mycoplasma 
Antibiotic  Production of toxin* 
PuromycinS 5 qt/ml 
"  1 ~//ml 
Puromycin aminonudeosideS 5 "//ml 
Aureomycin 5 "y/ml 
Kanamycin 5 T/ml 
0 
0 
++ 
0 
++ 
* Each  tube contained  10  n  thrice-washed  mycoplasmas per ml, suspended  in Ringer's 
solution, with 0.1 ~  phosphate buffer pH 7.5,  and glucose 0.5 mg per nil. The tubes were 
incubated for 45 min at 37°C, then centrifuged at 13,000 g for 15 rain, and the supematant 
fluid injected into 4 mice in dose of 0.5 ml each. Rolling disease and death indicated by ++. 
$ Obtained from Nutritional Biochemical Corp., Cleveland. 1096  STUDIES  OF  PPLO  INFECTION.  IV 
in dialysis sacs and submerged in broth, and also with organisms in phosphate 
buffer with glucose.  The aminonucleoside analogue of puromycin, which in- 
hibits RNA synthesis but not immediate protein synthesis (6,  7), had no in- 
hibitory action on toxin production during the same period. Aureomycin, in a 
concentration of 5 #g per ml, prevented toxin formation. Kanamycin, in the 
same concentration, did not inhibit synthesis. It is of interest that the anti- 
biotics which prevented synthesis had relatively little effect on the viability of 
the mycoplasmas during the 30 min period of incubation, while kanamycin had 
killed a substantial proportion by the end of this time. 
DISCUSSION 
Aside from  the  conspicuous  property of M.  neurolflicum  to  produce  an 
exotoxin in easily demonstrable quantities and the absence of exotoxin in the 
S-6  strain  of M.  gallisepticum  (5),  the  similarities between these organisms 
are quite striking. Both are acutely neurotoxic when injected as concentrated 
suspensions of live organisms. Both have a host specificity which appears to be 
nearly absolute; M. gallisepticum is neurotoxic only for turkey poults (5),  and 
M. neurolyticum affects mice and rats but no other known animal (2, 3). Both 
agents produce their toxins after injection into the animal; frozen-thawed ex- 
tracts  of  concentrated suspensions do  not  contain demonstrable toxin,  and 
pretreatment of the animals with tetracycline protects completely against the 
neurotoxicity of suspensions of both mycoplasmas. For M. neurolyticura,  anti- 
body is much more effective in protecting against the soluble exotoxin than 
against the neurotoxicity of whole organisms; no comparison can be made here 
with M. gallisepticum in the absence of an available exotoxin. 
The capacity of resting organisms of M. neurolyticum  to synthesize exotoxin 
in vitro has been demonstrated here,  and there is  no difficulty in imagining 
very rapid elaboration of the toxin after intravenous injection of suspensions 
of the whole organisms into animals offering a suitable environment. Indeed, it 
is surprising how simple are the requirements set by the mycoplasma for the 
production of toxin in vitro.  In phosphate buffer at  optimal pH,  and  with 
optimal amounts of glucose, a suspension of the organisms can, within 15 to 30 
rain, produce toxin in concentrations similar to those achieved by overnight 
cultures in whole PPLO broth. 
The demonstrated prevention of toxin formation in vitro by puromycin is 
evidence that protein synthesis is involved in the production of toxin by sus- 
pensions of mycoplasmas, rather than the release from preformed stores. The 
failure of the aminonucleoside analogue of puromycin to inhibit the elaboration 
of toxin is consistent with this view. In other systems, inhibition of formation 
of a cellular product by puromycin, and not by aminonucleoside, has been inter- 
preted as evidence for protein synthesis by the cell (6, 7). The lack of inhibition 
by kanamycin is  of special interest,  since it implies that toxin synthesis may 
proceed independently of the viability of the culture. LEWIS  THOMAS AND  MARK  W.  BITENSKY  1097 
M. neurolyticum is a microorganism of considerable speculative interest, as 
a possible model for necrotizing disease of unestablished pathogenesis. It can 
manufacture, rapidly, a specific  neurotoxin capable of distending most of the 
glial cells  of the brain with fluid within a  few hours,  leading to irreversible 
brain lesions suggestive by light microscopy, of ischemic necrosis,  associated 
with numerous foci of demyelination. The toxin can be produced by resting 
cells in vitro, and one might assume circumstances for its elaboration in vivo, 
from sites distant from the target organ. The organism does not have a  long 
survival period in the host animal, and may be difficult or impossible to detect 
at the time when the damage caused by its toxin is in evidence. As a representa- 
tive of a candidate class of microorganisms for implication in diseases currently 
obscure, it merits further attention and study. 
SUMMARY 
Concentrated  suspensions  of  washed  Mycoplasma neurolyticum produce 
rolling disease in mice and rats, with neurological manifestations and pathologi- 
cal lesions similar to those seen with the exotoxin of this organism. 
Pretreatment of animals with tetracycline protects completely against the 
toxic effects of washed suspensions of mycoplasmas, while tetracycline affords 
no protection against the exotoxin. Freeze-thawing disruption of mycoplasma 
suspensions eliminates their neurotoxicity, while the same treatment does not 
affect exotoxin. The toxicity of intact organisms is not affected by exposure to 
the sedimentable component of brain, nor to ganglioside. These observations 
are interpreted to indicate that the neurotoxicity of living mycoplasmas must 
be due to their production of toxin after they have been injected into the ani- 
mal. 
Resting mycoplasmas, suspended in Ringer's solution in dialysis sacs sub- 
merged in PPLO broth, produce considerable amounts of toxin within 15 min 
of  incubation  at  37°C.  Toxin  is  also  produced,  although  in somewhat  less 
amount, by washed organisms suspended in phosphate buffer containing glu- 
cose.  The formation of toxin is prevented by the presence of puromycin, but 
not by the aminonucleoside analogue of puromycin, indicating that active pro- 
tein synthesis is involved in the elaboration of toxin. 
The similarities between the neurotoxicity of the intact organisms of M. 
neurolyticum and Mycoplasma gallisepticum are discussed. 
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